Literature DB >> 23736929

Haemostasis and immunity: cross-talking systems?

Wilma Barcellini1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23736929      PMCID: PMC3934266          DOI: 10.2450/2013.0301-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

Review 1.  Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.

Authors:  Claudia Rizzo; Sergio Rizzo; Elisabetta Scirè; Danilo Di Bona; Carlo Ingrassia; Giovanni Franco; Roberto Bono; Gerlando Quintini; Calogero Caruso
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

2.  Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.

Authors:  Wilma Barcellini; Francesco Zaja; Anna Zaninoni; Francesca Guia Imperiali; Marta Lisa Battista; Eros Di Bona; Bruno Fattizzo; Dario Consonni; Agostino Cortelezzi; Renato Fanin; Alberto Zanella
Journal:  Blood       Date:  2012-01-20       Impact factor: 22.113

Review 3.  Rituximab therapy for autoimmune haematological diseases.

Authors:  Wilma Barcellini; Alberto Zanella
Journal:  Eur J Intern Med       Date:  2011-01-31       Impact factor: 4.487

Review 4.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

Review 5.  Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes.

Authors:  James N George; Zayd L Al-Nouri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012
  5 in total
  1 in total

1.  Pregnancy Induced Autoimmune Warm Antibodies Hemolytic Anemia: A Case Report.

Authors:  D Laužikienė; D Ramašauskaitė; T Lūža; R Lenkutienė
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.